Carregant...

The Impact of the Low Molecular Weight Heparin Tinzaparin on the Sensitization of Cisplatin-Resistant Ovarian Cancers—Preclinical In Vivo Evaluation in Xenograft Tumor Models

Resistance formation of tumors against chemotherapeutics is the major obstacle in clinical cancer therapy. Although low molecular weight heparin (LMWH) is an important component in oncology referring to guideline-based antithrombotic prophylaxis of tumor patients, a potential interference of LMWH wi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Molecules
Autors principals: Mueller, Thomas, Pfankuchen, Daniel Bastian, Wantoch von Rekowski, Kathleen, Schlesinger, Martin, Reipsch, Franziska, Bendas, Gerd
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2017
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6154624/
https://ncbi.nlm.nih.gov/pubmed/28467373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules22050728
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!